IU Philanthropic Venture Fund returned for a series A round expected to help MBX identify clinical-stage peptides for rare endocrine genetic diseases.

AbbVie Ventures and Sofinnova Partners have co-led a series A round for Enthera Pharmaceuticals, which is using stem cells to treat autoimmune disorders.

Tubulis has raised series A funding to progress an ADC development platform invented at Leibniz Research Institute and Ludwig Maximillians University.

Forge is working on a gene therapy treatment invented at UPMC but has covered its bases by targeting viral vector production for third-party clients.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

American Family and Scor participated in a round that will support the expansion of Branch's digital insurance platform through the United States.

Merck Global Health Innovation Fund and existing investor Cedars-Sinai took part in a $17m round for the blood collection technology provider.

Lockheed Martin Ventures helped the artificial intelligence-focused cybersecurity startup close a round that will fund R&D and global growth.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

T1 Esports, HP Tech Ventures and Axiomatic have all invested in an $11.3m round for the company, which plans to now enhance its esports performance analysis system.